🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

313,52 USD

Máx. histórico

322,75

4 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-2,86%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,12%

Cierre anterior

307,02

Rango de hoy

309,46 – 317,76

Volumen hoy

195.564

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
33,04 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 20 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/09/2021 83,33 84,23 81,42 82,37 -0,88% 3,38% 208.390
13/09/2021 85,41 85,41 82,43 83,10 -2,65% 3,49% 238.847
10/09/2021 85,43 87,31 85,14 85,36 +0,63% 2,54% 163.987
09/09/2021 85,05 86,71 82,48 84,83 -0,45% 4,98% 242.534
08/09/2021 82,21 85,28 81,16 85,21 +3,62% 5,02% 302.005
07/09/2021 85,85 86,69 81,77 82,23 -4,62% 5,73% 510.235
03/09/2021 87,26 88,70 85,15 86,21 -1,17% 4,07% 5.844.057
02/09/2021 87,34 88,88 86,00 87,23 +0,06% 3,30% 467.916
01/09/2021 82,01 87,27 81,53 87,17 +5,62% 7,01% 646.811
31/08/2021 79,17 84,26 78,70 82,53 +9,21% 7,03% 1.352.291
30/08/2021 71,78 75,98 71,34 75,57 +5,96% 6,46% 339.676
27/08/2021 69,70 72,09 69,35 71,32 +2,86% 3,94% 177.933
26/08/2021 70,54 71,68 69,25 69,34 -1,91% 3,45% 170.399
25/08/2021 71,96 73,13 70,19 70,69 -1,96% 4,09% 137.377
24/08/2021 72,85 73,45 70,93 72,10 -0,48% 3,46% 294.151
23/08/2021 65,51 72,60 65,51 72,45 +11,57% 10,82% 562.653
20/08/2021 63,68 66,01 63,68 64,94 +1,73% 3,66% 987.127
19/08/2021 65,30 65,86 63,64 63,84 -2,82% 3,40% 281.807
18/08/2021 66,94 67,68 65,48 65,69 -1,84% 3,29% 222.016
17/08/2021 66,24 68,21 66,24 66,92 +0,02% 2,98% 276.518
16/08/2021 66,13 68,07 64,88 66,91 +0,40% 4,82% 277.479
13/08/2021 67,92 68,28 66,57 66,64 -2,04% 2,52% 166.552
12/08/2021 68,78 69,79 67,44 68,03 -0,50% 3,42% 203.902
11/08/2021 69,13 69,82 68,03 68,37 -0,43% 2,59% 162.384
10/08/2021 68,62 68,94 66,68 68,67 +0,13% 3,30% 150.522
09/08/2021 69,33 69,41 67,67 68,58 -0,09% 2,52% 166.391
06/08/2021 67,79 69,34 67,17 68,64 +0,97% 3,20% 217.367
05/08/2021 68,56 68,76 67,11 67,98 -0,08% 2,41% 215.924
04/08/2021 68,91 69,96 68,03 68,03 -1,79% 2,79% 197.329
03/08/2021 69,35 69,69 67,81 69,28 +0,09% 2,71% 196.528